September 2021

De Novo Protein Sequencing

2021-10-05T08:01:38-04:00September 28th, 2021|Webinars|

Abstract In this on-demand webinar, we briefly cover the fundamentals of protein sequencing, how researchers have benefited from implementing protein sequencing into their pipelines, and discuss how Rapid Novor is able to routinely and robustly achieve 100% accuracy and 100% coverage for both monoclonal and oligoclonal antibodies. Webinar details [...]

Antibody Characterization by Mass Spectrometry

2021-10-05T08:03:18-04:00September 28th, 2021|Webinars|

Abstract In this on-demand webinar, we discuss why it is important to characterize antibodies based on their physical properties not just by what they bind, and how you can easily do the former via mass spectrometry-based protein sequencing. Key Takeaways Antibodies are generally characterized based on what they bind, not their [...]

Overcoming Irreproducibility in Life Science Research

2021-10-04T16:40:15-04:00September 28th, 2021|Webinars|

Overcoming Irreproducibility in Life Science Research Sponsored by: Rapid Novor, Inc & Absolute Antibody Our team, along with four other industry panelists, discuss ways to safeguard their research through recombinant antibodies, cell culturing procedures, antibody protein sequences, and reference identifiers. Full Webinar Panelists: Andrew Bradbury, CSO at Specifica “Drug-Like Antibodies from [...]

June 2021

The New Era in ADA Assays

2021-10-05T08:32:34-04:00June 7th, 2021|Webinars|

Anti-Drug Antibody (ADA) assays such as ligand-based assays are critical to assess the clinical efficacy and safety of a biological drug. ADA assays rely on control reagents that mimic the ADA response to the biological drug being tested. These positive controls typically consist of animal-derived (e.g., rabbits) pooled polyclonal antibodies (pAb) [...]

Polyclonal Antibody Sequencing with Only Proteomics

2021-10-05T08:27:24-04:00June 1st, 2021|Webinars|

Landing on the Moon with Mass Spectrometry: Polyclonal Sequencing with Only Proteomics Presented by Anthony Stajduhar, Director of International Business Development, Rapid Novor Over the past 5 years Rapid Novor has perfected monoclonal antibody sequencing, and is now sequencing mAbs from polyclonal mixtures using REpAb®.  After successfully launching their proteogenomics based [...]

March 2021

Webinar: Leveraging pAbs for Therapeutic Development

2021-10-05T08:25:49-04:00March 30th, 2021|Webinars|

Leveraging Polyclonal Antibody Sequence in Therapeutic Development Pipelines Presented by Anthony Stajduhar, Director of International Business Development, Rapid Novor Over the past several years Rapid Novor has been developing the world's best antibody protein sequencing platform, sequencing over 2700 monoclonal antibodies and proteins. In 2020, they unveiled their most advanced technology [...]

October 2020

Research Insurance with de novo Protein Sequencing

2021-10-04T16:37:54-04:00October 26th, 2020|Webinars|

Research Insurance with de novo Protein Sequencing Originally presented October 16, 2020 by Monique Seymour, International Scientific Sales Executive, Rapid Novor If you could have guaranteed stability, certainty, and reproducibility for your research, would you be interested? Imagine this, if you're 2 years into your project and your freezer died along [...]

September 2020

Leveraging Recombinant Patient Antibodies in Therapeutic Applications

2021-10-04T16:39:20-04:00September 3rd, 2020|Webinars|

Leveraging Recombinant Patient Antibodies in Therapeutic Applications Originally presented at PEGS Boston Virtual 2020 by Anthony Stajduhar, Director of International Business Development, Rapid Novor Our team has perfected the art of monoclonal antibody sequencing, and is now ready to demonstrate our ability to sequence mAbs from polyclonal mixtures. In this talk, Anthony [...]